Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Zika Virus Testing Industry Research Report 2024
... is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and ... Read More
-
Drugs for Malaria Industry Research Report 2024
... temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by ... Read More
-
Global Influenza Diagnostics Databank Market Report
... 2029. RT-PCR segment is expected to be the highest contributor to this market, with $339.2 Million in 2020, and is anticipated to reach $425.1 Million by 2029, registering a CAGR of 2.58%. Cell Culture segment ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Drugs for Malaria Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The ... Read More
-
Global Digital Diabetes Management Databank Market Report
... 2023 to 2031. Continuous Blood Glucose Monitoring System segment is expected to be the highest contributor to this market, with $4,876.9 Million in 2022, and is anticipated to reach $9,140.7 Million by 2031, registering a ... Read More
-
Global Castrate-resistant Prostate Cancer Databank Market Report
... 2023 to 2031. Hormonal Therapy segment is expected to be the highest contributor to this market, with $7,227.4 Million in 2022, and is anticipated to reach $12,564.7 Million by 2031, registering a CAGR of 6.39%. ... Read More
-
Global Artificial Pancreas Device System Databank Market Report.pdf
... 5.40% from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of ... Read More
-
Global Insomnia Therapeutics Databank Market Report
... 2031. Drugs segment is expected to be the highest contributor to this market, with $3,103.4 Million in 2022, and is anticipated to reach $4,664.6 Million by 2031, registering a CAGR of 4.67%. Medical Devices segment ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Global Cancer Registry Software Databank Market Report
... from 2023 to 2031. Integrated segment is expected to be the highest contributor to this market, with $35.1 Million in 2022, and is anticipated to reach $42.9 Million by 2031, registering a CAGR of 2.28%. Read More
-
Global Analgesic Infusion Pumps Databank Market Report
... 2023 to 2031. Patient-Controlled Analgesia Pump segment is expected to be the highest contributor to this market, with $5,519.1 Million in 2022, and is anticipated to reach $13,717.3 Million by 2031, registering a CAGR of ... Read More
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
-
Medical Tourism Market - By Application (Cosmetic Surgery {Hair Transplant, Breast Augmentation}, Cardiovascular Surgery, Orthopedic Surgery, Oncology Treatment, Dental Surgery, Bariatric Surgery, Fertility Treatment) & Forecast 2024 - 2032
... 16.3% CAGR between 2024 and 2032, driven by rising collaborations between leading facility providers. These partnerships are crucial in enhancing the overall patient experience, offering comprehensive healthcare packages that include advanced medical treatments, post-operative care, ... Read More
-
Biomarkers Market by Product & Service (Consumable, Software), Type (Safety, Efficacy), Research Area, Technology (NGS, PCR, Mass Spectrometry), Disease (Cancer, Infectious), Application (Diagnostics, Clinical Research) - Global Forecast to 2029
... to reach USD 93.8 billion in 2029 from USD 57.7 billion in 2024, at a CAGR of 10.2% during the forecast period. The growth of this market can be attributed to the advantage that these ... Read More
-
Post-operative Pain (POP) - Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast for POP. Most marketed drugs for POP are enzyme inhibitors, followed by receptor agonists, by mechanism of action. Phase III pipeline for POP is robust and includes ... Read More
-
Global Hepatitis A Vaccine Market Analysis and Forecast 2024-2030
... age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally" 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric ... Read More
-
Global Hepatitis A Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
... HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Tuberculosis (TB) Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, ... Read More
-
Epilepsy - Global Clinical Trials Review, 2024
... the clinical trials on Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Pulmonary Tuberculosis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Pulmonary Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Digital Marketing Trends in Type 2 Diabetes - April 2024
... 2023 to March 2024. This was followed by Rybelsus.com with over 9,000,000 visits. Overall, the highest proportion of traffic to top branded patient T2D websites originated from direct sources, followed by organic sources. Farxiga.com had ... Read More
-
Middle East and Africa Stem Cell Therapy Market, By Type (Allogenic Stem Cell Therapy, Autologous Stem Cell Therapy); By Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-derived MSCs, Placental/Umbilical Cord-derive MSCs); By Therapeutic Application (Musculoskeletal Disorders, Wounds & Surgeries, Cardiovascular Diseases, Inflammatory & Autoimmune, Neurological Disorders); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Middle East and Africa (MEA)), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Wounds & Surgeries, Cardiovascular Diseases, Inflammatory & Autoimmune, Neurological Disorders); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Middle East and Africa (MEA)), Trend Analysis, Competitive Landscape & Forecast, ... Read More
Research Assistance
